Companies: 10,795·Total market cap: $144.5T
Edap Tms S.a.

Edap Tms S.a.

EDAPNASDAQHealthcare
$4.76
$-0.03(-0.52%)
Market Cap$178226839
P/E Ratio
52W High$5.05
52W Low$1.21
Overview

Edap Tms S.a. (EDAP) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

edap · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Edap Tms S.a. (EDAP) measures how much investors pay for each dollar of the company's trailing earnings. EDAP's current PE ratio of N/A is calculated by dividing its stock price of $4.75 by its TTM earnings per share of -$0.82.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.60
Based on 2 analysts
EPS (TTM)
-$0.82
TTM · diluted EPS
PEG Ratio
0.15
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Edap Tms S.a. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 86.6x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 4 fiscal years · Front-end computed
Average
86.6x
4-yr mean
Median
49.2x
4-yr midpoint
Minimum
6.2x
Lowest year
Maximum
241.8x
Highest year
6.2x
Min
Q1 · 25%49.2x
Median
Q3 · 75%241.8x
Max
Historically Low

At N/A, EDAP's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.

0th percentileHigher than 0 of 4 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Edap Tms S.a.
Edap Tms S.a.You
EDAP
$178MN/A-$0.82
Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock
ACRV
$44MN/A-$2.02
Fortress Biotech, Inc.
Fortress Biotech, Inc.
FBIO
$95M14.98x$0.24
Hyperfine, Inc.
Hyperfine, Inc.
HYPR
$119MN/A-$0.38
InterCure Ltd.
InterCure Ltd.
INCR
$54MN/A-$0.63
Pulmonx Corporation
Pulmonx Corporation
LUNG
$63MN/A-$1.33
Spectral AI, Inc.
Spectral AI, Inc.
MDAI
$59MN/A-$0.29

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.78
2024-12-31
FY2024
$-0.51
2023-12-31
FY2023
$-0.57
2022-12-31
FY2022
$-0.09
2021-12-31
FY2021
241.78x$0.02
2020-12-31
FY2020
$-0.06
2019-12-31
FY2019
75.81x$0.05
2018-12-31
FY2018
$-0.01
2017-12-31
FY2017
$-0.02
2016-12-31
FY2016
22.56x$0.14

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Edap Tms S.a. (EDAP) measures how much investors pay for each dollar of the company's trailing earnings. EDAP's current PE ratio of N/A is calculated by dividing its stock price of $4.75 by its TTM earnings per share of -$0.82.

PE Ratio = Stock Price ÷ EPS (TTM)
= $4.75 ÷ -$0.82 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

EDAP pe ratio · 6 questions

EDAP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.75 and TTM EPS of -$0.82. Data sourced from Financial Modeling Prep via EDAP's SEC 10-K and 10-Q filings.

EDAP PE ratioWhat is EDAP PE ratioCurrent PE ratio of EDAPEDAP PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Edap Tms S.a. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09